Skip to main content
Premium Trial:

Request an Annual Quote

Brutlag Named Chair of Strata's Scientific Board

Premium

ALAMEDA, Calif.--Privately funded functional genomics company Strata Biosciences named bioinformatics expert Douglas Brutlag chairman of its scientific advisory board. Brutlag is professor of biochemistry and medicine and director of the Bioinformatics Resource at Stanford's School of Medicine. He also serves on the scientific advisory boards of Pangea Systems and Time Logic, and the editorial board of the Journal of Computational Biology, and he cofounded the International Society of Computational Biology. In 1980, Brutlag cofounded the companies IntelliGenetics and IntelliCorp.

Brutlag began his career as a research scientist at the Commonwealth Scientific and Industrial Research Organization in Canberra, Australia, before joining the Stanford faculty.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.